Sort   by:  
 Page size 
UnknownSerum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
Not available
S-EPMC4990178 | biostudies-literature
UnknownPlasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome-a clinical pilot study.
Not available
S-EPMC12283730 | biostudies-literature
UnknownActivity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
Not available
S-EPMC9484698 | biostudies-literature
UnknownEndothelial dysfunction in ME/CFS patients.
Not available
S-EPMC9894436 | biostudies-literature
UnknownReduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Results From Open-Label Cyclophosphamide Intervention Study.
Not available
S-EPMC8019750 | biostudies-literature
UnknownTreatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway.
Not available
S-EPMC7959220 | biostudies-literature
UnknownBenefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.
Not available
S-EPMC3198463 | biostudies-literature
TranscriptomicsMolecular portraits of human breast tumors
Set of 65 surgical specimens of human breast tumors from 42 different individuals, using complementary DNA microarrays representing 8,102 human genes. Gene expression variation patterns within this set provided a distinctive molecular portrait of each tumor. Twenty of the tumors were sampled twice, ...
ORGANISM(S): Homo sapiens 
2002-06-27 | E-GEOD-61 | biostudies-arrayexpress
UnknownB-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
Not available
S-EPMC4488509 | biostudies-literature
UnknownSix-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Not available
S-EPMC11265720 | biostudies-literature
Sort   by:  
 Page size